These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1068739)

  • 1. Clinico-pathologic correlation of liver damage in patients treated with 6-mercaptopurine and Adriamycin.
    Minow RA; Stern MH; Casey JH; Rodriguez V; Luna MA
    Cancer; 1976 Oct; 38(4):1524-8. PubMed ID: 1068739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination 6-mercaptopurine-adriamycin in refractory adult acute leukemia.
    Rodriguez V; Bodey GP; McCredie KB; Freireich EJ; Minow RA; Casey JH; Luna M
    Clin Pharmacol Ther; 1975 Oct; 18(4):462-6. PubMed ID: 1100309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.
    Björnsson ES; Gu J; Kleiner DE; Chalasani N; Hayashi PH; Hoofnagle JH;
    J Clin Gastroenterol; 2017 Jan; 51(1):63-69. PubMed ID: 27648552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations of free anthraquinones from rhubarb against alpha-naphthylisothiocyanate-induced cholestatic liver injury in rats.
    Zhao YL; Wang JB; Zhou GD; Shan LM; Xiao XH
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):463-9. PubMed ID: 19389047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic injury during doxorubicin therapy.
    Avilés A; Herrera J; Ramos E; Ambriz R; Aguirre J; Pizzuto J
    Arch Pathol Lab Med; 1984 Nov; 108(11):912-3. PubMed ID: 6548368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined treatment of myeloid leukemia with cytosine arabinoside and 6-mercaptopurine].
    Lawkowicz W; Polubiec A; Domańska B
    Pol Tyg Lek; 1973 Jun; 28(23):865-7. PubMed ID: 4515923
    [No Abstract]   [Full Text] [Related]  

  • 7. Daunorubicin and adriamycin in the treatment of leukemia.
    Klener P; Donner L; Kozená J
    Neoplasma; 1973; 20(1):87-96. PubMed ID: 4573873
    [No Abstract]   [Full Text] [Related]  

  • 8. Jaundice and hepatorenal syndrome associated with cytosine arabinoside.
    Kirtley DW; Votaw ML; Thomas E
    J Natl Med Assoc; 1990 Mar; 82(3):209, 213, 217-8. PubMed ID: 2319616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-thioguanine as a cause of toxic veno-occlusive disease of the liver.
    Satti MB; Weinbren K; Gordon-Smith EC
    J Clin Pathol; 1982 Oct; 35(10):1086-91. PubMed ID: 6957419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinduction therapy for adult acute leukemia with adriamycin, vincristine, and prednisone: a Southwest Oncology Group study.
    Elias L; Shaw MT; Raab SO
    Cancer Treat Rep; 1979 Aug; 63(8):1413-5. PubMed ID: 289442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adriamycin-aclacinomycin therapy (AA therapy) for acute leukemia unresponsive to BH-AC-DMP therapy].
    Kobayashi M; Tahara T
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1473-9. PubMed ID: 6575727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible hepatotoxicity related to amphotericin B.
    Miller MA
    Can Med Assoc J; 1984 Nov; 131(10):1245-7. PubMed ID: 6594184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal hepatotoxicity associated with 6-mercaptopurine therapy.
    Laidlaw ST; Reilly JT; Suvarna SK
    Postgrad Med J; 1995 Oct; 71(840):639. PubMed ID: 8545299
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.
    Carey RW; Ribas-Mundo M; Ellison RR; Glidewell O; Lee ST; Cuttner J; Levy RN; Silver R; Blom J; Haurani F; Spurr CL; Harley JB; Kyle R; Moon JH; Eagan RT; Holland JH
    Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute leukemia complicated by hyperbilirubinemia due to high dose cytosine arabinoside therapy].
    Hashimoto M; Seekikawa I; Saito K; Horie S; Ishiyama T; Sugimoto M; Wakabayashi Y; Hirose S
    Rinsho Ketsueki; 1989 Feb; 30(2):262-5. PubMed ID: 2746881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neonatal complication of maternal leukaemia treated with 6-mercaptopurine.
    McConnell JB; Bhoola R
    Postgrad Med J; 1973 Mar; 49(569):211-3. PubMed ID: 4528388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant DL-alpha lipoic acid as an attenuator of adriamycin induced hepatotoxicity in rat model.
    Anandakumar PP; Malarkodi SP; Sivaprasad TR; Saravanan GD
    Indian J Exp Biol; 2007 Dec; 45(12):1045-9. PubMed ID: 18254210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity in the treatment of acute lymphoblastic leukaemia.
    Topley JM; Benson J; Squier MV; Chessells JM
    Med Pediatr Oncol; 1979; 7(4):393-9. PubMed ID: 296787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Adriamycin in acute leukaemia.
    Smith IE; McElwain TJ
    Lancet; 1974 Jul; 2(7873):161. PubMed ID: 4135524
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytosine arabinoside in the treatment of acute myeloblastic leukaemia.
    Bailey CC; Geary CG; Israëls MC; Whittaker JA; Brown MJ; Weatherall DJ
    Lancet; 1971 Jun; 1(7712):1268-71. PubMed ID: 4104719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.